Security Snapshot

DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) Institutional Ownership

CUSIP: 25459Y876

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

14

Shares (Excl. Options)

51,155

Price

$91.57

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-98,776
Value change
-$9,681,880
Number of holders
14
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$90.16
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CURE - DIREXION SHS ETF TR - HEALTHCARE BUL is tracked under CUSIP 25459Y876.
  • 14 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 20 to 14 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $16,743,058 to $4,659,140.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 14 institutions filings for Q1 2026.

Open SEC evidence

Security key

25459Y876

Latest holder period

Q1 2026

13F holders

14

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 14 institutional investors reported holding 51,155 shares of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 51,155 $4,659,140 -$9,681,880 $91.57 14
2025 Q4 150,081 $16,743,058 -$582,709 $111.56 20
2025 Q3 176,977 $15,149,117 +$6,201,048 $83.52 23
2025 Q2 104,829 $8,738,642 -$2,121,036 $78.82 21
2025 Q1 119,630 $12,749,419 -$3,651,625 $106.61 21
2024 Q4 162,215 $14,967,674 +$2,061,776 $92.29 23
2024 Q3 117,641 $14,975,249 -$10,934,696 $133.18 19
2024 Q2 209,029 $24,832,086 -$619,320 $116.81 21
2024 Q1 212,892 $26,661,184 +$41,524 $125.45 23
2023 Q4 212,898 $21,651,140 +$427,610 $101.74 21
2023 Q3 211,193 $18,695,500 +$3,185,404 $88.53 20
2023 Q2 172,863 $17,292,257 +$3,960,918 $100.01 20
2023 Q1 111,129 $10,668,334 +$5,851,532 $96.00 13
2022 Q4 48,370 $5,550,191 -$3,013,993 $114.76 20
2022 Q3 75,620 $6,384,394 +$4,299,088 $84.44 18
2022 Q2 24,736 $2,549,132 -$6,683,921 $103.08 17
2022 Q1 82,130 $10,714,439 -$2,026,081 $130.45 22
2021 Q4 93,191 $13,512,085 +$5,665,143 $144.96 20
2021 Q3 59,622 $6,415,296 +$3,553,188 $107.43 19
2021 Q2 26,189 $2,785,000 -$5,481,399 $104.58 14
2021 Q1 90,189 $7,533,644 -$4,130,827 $83.51 15
2020 Q4 144,746 $11,147,104 +$4,022,795 $77.00 17
2020 Q3 92,309 $5,870,731 -$7,543,034 $63.02 13
2020 Q2 215,776 $11,724,759 +$1,931,782 $54.33 15
2020 Q1 180,011 $7,164,157 -$2,162,962 $39.83 13
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .